Related Experiment Video

Updated: Jul 4, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

[Two cases of severe necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus]

Yusuke Tomita1, Osamu Kawano, Hidenori Ichiyasu

  • 1Department of Respiratory Medicine, Kumamoto Saishunso National Hospital.

Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society
|June 4, 2008
PubMed

Insights

Severe necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) occurred in two Japanese patients without typical risk factors. The absence of Panton-Valentine leukocidin (PVL) suggests other factors contribute to CA-MRSA severity.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is an emerging pathogen.
  • Necrotizing pneumonia is a severe lung infection with high morbidity and mortality.
  • CA-MRSA infections typically occur in individuals with specific risk factors.

Observation:

  • Two patients in Japan, an elderly man and a young student, presented with severe necrotizing pneumonia.
  • Chest imaging revealed multiple consolidations and cavitary lesions indicative of necrotizing pneumonia.
  • Strains identified as CA-MRSA were isolated from sputum cultures upon admission.

Findings:

  • Neither patient had established risk factors for MRSA infection, meeting Centers for Disease Control and Prevention (CDC) criteria for CA-MRSA.
  • Despite intensive treatment, one patient succumbed to the CA-MRSA pneumonia.
  • Panton-Valentine leukocidin (PVL) genes were not detected in the isolated CA-MRSA strains.

Implications:

  • This case series represents the first report of severe necrotizing pneumonia due to CA-MRSA in Japan.
  • The findings suggest that factors beyond PVL may drive the severity of CA-MRSA necrotizing pneumonia.
  • Further research is needed to understand the pathogenesis and identify risk factors for severe CA-MRSA infections in diverse populations.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...